Supadelixir Inc.
Chuncheon-si, KR· latest recorded location
SUPADELIXIR INC. is named on 7 US grants and 14 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 7
- Published applications
- 14
- Inventors
- 9
- Granted in 2026 so far
- 0
- Most recent grant
- 29 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 21 documents
Recent patents
- Composition comprising P53-activating peptide29 Jul 2025US 12,370,234 B2
- SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same21 Apr 2020US 10,626,157 B2
- Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same16 Jan 2018US 9,868,775 B2
- Composition comprising peptide derived from adiponectin18 Apr 2017US 9,624,286 B2
- Microphthalmia-associated transcription factor-derived peptide and composition containing same15 Nov 2016US 9,493,528 B2
- Peptide activating retinoic acid receptor, and cosmetic composition containing same13 Aug 2026US 2026/0232561 A1
- Peptide inhibiting formation of snare complexes, and cosmetic composition containing same16 Jul 2026US 2026/0200973 A1
- Peptide activating vitamin d receptor, and cosmetic composition containing same25 Jun 2026US 2026/0174818 A1
- Composition comprising p53-activating peptide26 Jan 2023US 2023/0021365 A1
- Pharmaceutical composition comprising peptide that inhibits interaction of p53 and foxo426 Jan 2023US 2023/0023726 A1
Most cited
By later US patents